OVERVIEW

CATALYST: The Immuno-oncology Revolution Continues: A 3D View Chapter 2: Mechanisms of Immune Escape is organized by Med Learning Group and will be held from Mar 29, 2019 - Mar 29, 2020.

Target Audience:
This initiative is designed to meet the educational needs of community and academic medical oncologists, hematologists, allied health and advanced practitioners (NP, PA, PharmD), and other relevant healthcare professionals involved in immuno-oncology, precision medicine, and treatment decision-making in cancer.

Accreditation:
Credit Designation Statement
Med Learning Group designates this online activity for a maximum of 0.50 AMA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent for their participation in the online activity.

Nursing Credit Information
Purpose: This program would be beneficial for nurses involved in the long-term treatment and management of patients with cancer. CNE Credits: 0.50 ANCC Contact Hour(s).

Description:
This 5-part educational activity will cover the treatment and management of patients with cancer who are on or considering immunotherapy, and will focus on aspects of care in this area such as mechanisms of cancer and targeted therapies, immune-related adverse events, investigational directions, and other immunotherapy-related treatment decisions.

Learning Objectives:
Upon completion of the program, attendees should be able to:
• Discuss the pathophysiology of adult malignancies with a focus on tumor immunosurveillance and immune evasion
• Review significant advances and unmet medical needs associated with currently available immuno-oncology therapies including innate and adaptive resistance mechanisms (eg, T-cell exhaustion)
• Describe immune pathways that may be targeted to overcome immune-evasion mechanisms and emerging clinical data on novel immuno-oncology agents.

Additional details will be posted as soon as they are available.